128-62-1 |
NARCOTINE |
Tusscapine |
Methoxyhydrastine |
Terbenol |
Capval |
Coscopin |
Narcompren |
Narcosine |
Vadebex |
(-)-Narcotine |
Longatin |
Narcotin |
Narkotin |
Noscapalin |
Noscapin |
Opianine |
Opianin |
Narcotussin |
Nectadon |
Nicolane |
Nipaxon |
Lyobex |
Opian |
alpha-Narcotine |
O-Methylnarcotoline |
Coscotabs |
Noscapinum |
Key-tusscapine |
Longactin |
Noscapal |
Noscapina |
Hederix (free base) |
(-)-alpha-narcotine |
L-alpha-Narcotine |
Narcotinum |
Noscopine |
Noskapin |
(-)-.alpha.-Narcotine |
NSC 5366 |
NSC-5366 |
L-alpha-Noscapine |
8-Methoxyhydrastin |
.alpha.-Narcotine |
Coscopin (VAN) |
dl-Narcotine |
(+-)-Noscapine |
(+/-)-Noscapine |
L-.alpha.-Narcotine |
(-)-alpha-Norcotine |
(+-)-alpha-Narcotine |
Noscapinum [INN-Latin] |
(S,R)-Noscapine |
Noscapina [INN-Spanish] |
UNII-A4C6WE7BZN |
A4C6WE7BZN |
UNII-8V32U4AOQU |
8V32U4AOQU |
alpha-Gnoscopine |
CCRIS 9304 |
(S)-6,7-dimethoxy-3-((R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)isobenzofuran-1(3H)-one |
DTXSID4023385 |
CHEBI:73237 |
HSDB 3372 |
Noscapine [USP:INN:BAN:JAN] |
Noscapine dl-form |
NSC5366 |
EINECS 204-899-2 |
(3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-2-benzofuran-1(3H)-one |
(3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-2-benzofuran-1-one |
Noscapine HCl |
BRN 0099933 |
(3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-2H,5H,6H,7H,8H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-1,3-dihydro-2-benzofuran-1-one |
1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-((5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (3S)-rel- |
1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)-isoquinolin-5-yl), (S-(R*,S*))- |
1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (R*,S*)- |
4-27-00-06838 (Beilstein Handbook Reference) |
DTXCID303385 |
6035-40-1 |
C22H23NO7 |
Narcotine alkaloid |
.alpha.-Gnoscopine |
NSC 96350 |
Noscapine (narcotine) |
(-)-3-(2-Methyl-6,7-methylendioxy-8-methoxy-1-isochinolyl)-6,7-dimethoxyphthalid |
Narcotine, (+-)- |
5-(6,7-Dimethoxyphthalidyl)-5,6,7,8-tetrahydro-4-methoxy-8-methyl-1,3-dioxolo(4,5-g)isoquinoline |
L-alpha-2-Methyl-8-methoxy-6,7-methylenedioxy-1-(6,7-dimethoxy-3-phthalidyl)-1,2,3,4-tetrahydroisoquinaline |
SMR000059119 |
Narcotine, (.+.)- |
(-)-.alpha.-Norcotine |
Noscapine [INN:BAN:JAN] |
1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (S-(R*,S*))- |
1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-, [S-(R*,S*)]- |
C22-H23-N-O7 |
NSC-96350 |
methoxyhydra-stine |
.beta.-Narcotine |
Noscapine (TN) |
(-)-noscapine |
NCGC00016388-01 |
[S-(R*,S*)]-6,7-Dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-1(3H)-Isobenzofuranone |
08N |
1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-((5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (3S)- |
1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-, (3S)- |
CAS-128-62-1 |
Prestwick_959 |
(-)-a-Narcotine |
1-.alpha.-Narcotine |
Tocris-1697 |
NOSCAPINE [INN] |
NOSCAPINE [JAN] |
NOSCAPINE [MI] |
NOSCAPINE [HSDB] |
Prestwick0_000563 |
Prestwick1_000563 |
Prestwick2_000563 |
Prestwick3_000563 |
NARCOTINUM [HPUS] |
CBMicro_048259 |
D0Y8AW |
NOSCAPINE [MART.] |
NOSCAPINE [USP-RS] |
NOSCAPINE [WHO-DD] |
NOSCAPINE [WHO-IP] |
SCHEMBL4559 |
Noscapine [BAN:INN:JAN] |
(S,R)-Noscapine, 97% |
Lopac0_000840 |
BSPBio_000346 |
MLS000069475 |
MLS001060855 |
SPBio_002565 |
Noscapine (JP15/USP/INN) |
Noscapine (JP17/USP/INN) |
BPBio1_000382 |
CHEMBL364713 |
NOSCAPINE DL-FORM [MI] |
NOSCAPINE [EP MONOGRAPH] |
NOSCAPINE, (+/-)- |
GTPL10212 |
NOSCAPINE [USP MONOGRAPH] |
NOSCAPINUM [WHO-IP LATIN] |
DTXSID901032089 |
HMS1569B08 |
HMS2096B08 |
HMS2269P05 |
1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-, (R*,S*)-(.+.)- |
6,7-Dimethoxy-3-(4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-2-benzofuran-1(3H)-one, (S-(R*,S*))- # |
Phthalide, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)- |
(+/-)-.ALPHA.-NARCOTINE |
Tox21_110413 |
BBL012344 |
BDBM50424716 |
CB3304 |
MFCD00069316 |
NSC121869 |
STK054401 |
Noscapine 1.0 mg/ml in Acetonitrile |
AKOS000278036 |
Tox21_110413_1 |
CCG-204096 |
CS-5115 |
DB06174 |
NSC-121869 |
SDCCGSBI-0048054.P004 |
NCGC00023230-02 |
NCGC00023230-04 |
NCGC00023230-05 |
NCGC00023230-07 |
NCGC00023230-08 |
NCGC00023230-10 |
NCGC00023230-14 |
(3S)-6,7-Dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-1(3H)-isobenzofuranone |
AC-20272 |
AC-33191 |
HY-13716 |
NCI60_004322 |
VS-03291 |
BIM-0048054.P001 |
C09592 |
D01036 |
EN300-24402818 |
SR-01000075529-6 |
W-201012 |
BRD-K89237706-001-03-8 |
Q60998699 |
Noscapine, European Pharmacopoeia (EP) Reference Standard |
Noscapine, United States Pharmacopeia (USP) Reference Standard |
WLN: T C566 DO FO KN EH & & TJ HO1 K1 J-DT56 BVO DHJ HO1 IO1 |
(3S)-3-[(5R)-6-methyl-4-(methyloxy)-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-6,7-bis(methyloxy)-2-benzofuran-1(3H)-one |
(3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-isobenzofuran-1-one |
1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8- tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin -5-yl)-, [S-(R,S)]- |
1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (R*,S*)-(+-)- |
1(3H)-Isobenzofuranone,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-, [S-(R*,S*)]- |
Phthalide,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)- |
There are more than 10 synonyms. If you wish to see them all click here.
|